First, T2D is often associated with insulin resistance, unstable insulin concentrations, reduced ability of the liver to inhibit inappropriate hepatic glycogen release, and reduced ability of β-cells to overcome insulin resistance. This evidence concerns the gene INS and Insulin resistance.